Association of Serum Total Bilirubin with Serum High Sensitivity C-reactive Protein in Middle-aged Men

Kiwoong Yu1, Cheolhwan Kim, Eunju Sung

  • 1Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

Higher serum total bilirubin (sTB) levels are linked to lower cardiovascular disease (CVD) risk factors in Korean men. This study found an inverse association between sTB and high sensitivity C-reactive protein (hsCRP), a key CVD indicator.

Area of Science:

  • Biochemistry
  • Cardiovascular Health
  • Public Health

Background:

  • Bilirubin's antioxidant properties suggest a potential inverse relationship with cardiovascular disease (CVD).
  • Limited data exist on serum total bilirubin (sTB) and CVD risk factors in the Korean population.
  • High sensitivity C-reactive protein (hsCRP) is an established independent risk factor for CVD.

Purpose of the Study:

  • To investigate the association between serum total bilirubin (sTB) and high sensitivity C-reactive protein (hsCRP) in Korean men.
  • To determine if sTB levels correlate with other cardiovascular disease risk factors.

Main Methods:

  • A cross-sectional study involving 6,800 Korean men was conducted.
  • Subjects were grouped by serum hsCRP levels (above or below 1.0 mg/L) and by quartiles of sTB.
  • Multivariate logistic regression analysis adjusted for known CVD risk factors.

Main Results:

  • Serum hsCRP showed significant associations with BMI, smoking, diabetes, hypertension, fasting plasma glucose, systolic blood pressure, alanine aminotransferase, and TC/HDL-C ratio.
  • Increasing sTB levels correlated with decreased age, smoking rates, BMI, and TC/HDL ratio.
  • Compared to the lowest quartile, higher sTB quartiles demonstrated a significant inverse relationship with hsCRP levels (ORs ranging from 0.82 to 0.63).

Conclusions:

  • Bilirubin levels may be inversely associated with hsCRP.
  • This suggests a potential protective role of bilirubin against cardiovascular disease risk in Korean men.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...